Search

2001 JAN 16 - (NewsRx.com & NewsRx.net) -- Trying to adjust interferon (IFN) treatment doses to fit hepatitis C viral load in HIV patients just doesn't work, researchers in Italy [...]

2001 JAN 15 - (NewsRx.com & NewsRx.net) -- Trying to adjust interferon (IFN) treatment doses to fit hepatitis C viral load in HIV patients just doesn't work, researchers in Italy [...]

2000 OCT 3 - (NewsRx.com) -- Interferon therapy is a common method of treatment for patients with hepatitis C virus (HCV). However, some people respond better to interferon therapy than [...]

2000 OCT 3 - (NewsRx.com) -- Interferon therapy is a common method of treatment for patients with hepatitis C virus (HCV). However, some people respond better to interferon therapy than [...]

Interferon Treatment for Hepatitis C Prevents Hepatocellular Cancer Abstract & Commentary Synopsis: In a large, retrospective series of hepatitis C patients, most of whom were treated with interferon, factors associated [...]

(CW HENDERSON PUBLISHER www.newsfile.com) -- Combination therapy with interferon and amantadine could offer an advantage in the treatment of chronic hepatitis C. The in vitro effects of amantadine (1-5 microM) [...]

Nomura, H.; Tsuchiya, Y; Maruyama, T.; Miki, K; Yokota, T.; Okubo, H. 'The Effects of a High Dose, Short Course of Interferon on Hepatitis C.' Journal of Gastroenterology and Hepatology, [...]

Prevention of Hepatocellular Carcinoma in Interferon-Treated Viral Hepatitis Patients ABSTRACT & COMMENTARY Synopsis: In this analysis, patients with hepatitis B or C with associated Child's A cirrhosis were matched for [...]

Synopsis: Natilizumab will become an important option for newly diagnosed MS patients starting treatment, or for patients currently on interferon beta-1a or glatiramer acetate with refractory breakthrough disease. ********** BIOGEN [...]

Two studies published in the July 29 issue of New England Journal of Medicine have found high efficacy rates among patients coinfected with chronic hepatitis C virus (HCV) and HIV [...]

Chronic hepatitis C may be effectively treated with high doses of interferon, a Japanese researcher reports. Interferon can counteract HPC-induced increases in alanine aminotransferase (ALT) activity, often restoring ALT activities [...]

Evidence for the Elevation of Serum Carcinoembryonic Antigen and Tumor-Associated Glycoprotein-72 Levels in Patients Administered Interferons SOURCE: Cancer Research, August 15, 1991;51:4155-4163. The administration of interferons to patients with adenocarcinoma [...]

SOURCE: Cancer Research, August 15, 1991;51:4155-4163. Interferon administration to patients with adenocarcinoma can result in increased serum levels of selected tumor-associated antigens used in the diagnosis of malignancies, suggesting a [...]

SOURCE: Journal of Clinical Oncology, May, 1991;9(5):783-788. A 19 percent response rate was seen in a group of children with brain and spinal cord tumors enrolled in a phase I-II [...]

AUTHORS: M. Tara, T. Okadome and K. Niiha, Kagoshima City Hospital; and M. Johnosono, I. Maruyama and M. Osame, Kagoshima University, Kagoshima, Japan. According to the abstract submitted by the [...]

Kenya Ninety-nine of 101 AIDS patients are free of symptoms after eight weeks of treatment with an oral alpha interferon formulation, a Kenyan medical researcher told a meeting in Japan. [...]

AUTHORS: H.G. Klingermann, A. Grigg, A.C. Eaves, K. Wilkie-Boyd, M.J. Barnett, D.E. Reece, J.D. Shepherd and G.L. Phillips. Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, British Columbia. According to [...]

AUTHORS: M. Tara, T. Okadome and K. Niiha, Kagoshima City Hospital; and M. Johnosono, I. Maruyama and M. Osame, Kagoshima University, Kagoshima, Japan. According to the abstract submitted by the [...]

LOW-DOSE INTERFERON RESPONSE DISCOURAGING Low-dose interferon does not appear to be adequate in the treatment of hairy cell leukemia, according to a recent clinical trial. Leukenia patients treated with interferon [...]

BIOLOGIC RESPONSE WITH IFN D. Goldstein and colleagues at the Department of Human Oncology, University of Wisconsin, have found that interferon-beta serine produces a host of biologic response modifications in [...]

'Interferon (IFN) Alpha + AZT in AIDS-Associated Kaposi's Sarcoma (KS): FinalResults of a Phase I Trial.' According to the abstract of the author's poster presentation at the V International Conference [...]

'Correlation of Effects of Interferon-Alpha in AIDS-Associated Kaposi's Sarcoma with Serum Levels an d Dose.' According to the abstract of the authors' poster presentation at the V International Conference on [...]